首页> 外文期刊>Journal of dairy science >Short communication: Determination of the milk pharmacokinetics and depletion of milk residues of flunixin following transdermal administration to lactating Holstein cows
【24h】

Short communication: Determination of the milk pharmacokinetics and depletion of milk residues of flunixin following transdermal administration to lactating Holstein cows

机译:短期通信:在透皮给药后泌乳蛋白后蜕膜乳蛋白的牛奶药代动力学和耗尽乳蛋白的测定

获取原文
获取原文并翻译 | 示例
       

摘要

Flunixin is a nonsteroidal anti-inflammatory drugand the most commonly prescribed analgesic in cattlein the United States. Recently, the US Food and DrugAdministration (FDA) approved a transdermal formulationof flunixin for control of pyrexia associated withbovine respiratory disease and the control of pain associatedwith foot rot. The transdermal formulation isnot currently approved for use in lactating dairy cattlein the United States, but extra-label use in dairy cattleis permissible under US regulations. The objectives ofthis study were to determine the pharmacokinetics inmilk of dairy cows treated with transdermal flunixinand determine an appropriate withdrawal time formilk. Ten lactating Holstein cows were enrolled intothe study in mid lactation. Following treatment, cowswere milked 3 times per day through 144 h. Milksamples were collected for drug analysis using ultrahigh-pressure liquid chromatography coupled with atriple quadrupole mass spectrometer. The geometricmean maximum concentration for flunixin in milkwas 0.010 μg/mL and was 0.061 μg/mL for the activemetabolite, 5-hydroxyflunixin. The geometric meanterminal half-life was 20.71 h for flunixin and 22.62 hfor 5-hydroxyflunixin. Calculations to approximate awithdrawal time in milk following transdermal flunixinadministration were accomplished using a statisticaltolerance limit procedure. This analysis indicated thatit would be prudent to observe a withdrawal period of96 h following the last treatment. This is more thantwice as long as the labeled withdrawal period of 36 hfollowing use of the injectable formulation. The withdrawalperiod suggested by this work should be appliedcarefully, as this study was not conducted underthe full quality control practices required by the USFDA for a full drug approval study. Caution should betaken when applying this withdrawal time to diseasedanimals, animals that are milked with different milkingfrequencies, and those in different stages of productionas these have all been shown to affect drug depletionfrom milk.
机译:Flunixin是一种非甾体抗炎药以及牛中最常见的镇痛药在美国。最近,美国食品和药物管理(FDA)批准了透皮制剂氟胺治疗蠕虫蛋白牛呼吸道疾病和相关的疼痛脚腐烂。透皮制剂是目前批准用于哺乳奶牛的用途在美国,但在奶牛的额外标签使用在美国法规下允许。目标的目标本研究是确定药代动力学用透皮弗卢宾蛋白治疗的奶牛牛奶并确定适当的退出时间牛奶。十个哺乳期荷斯坦奶牛被纳入中哺灭的研究。治疗后,奶牛每天挤奶3次,通过144小时。牛奶使用超高 - 捕获样品用于药物分析 - 压力液相色谱与a相结合三重四极孔质谱仪。几何牛奶中的氟丁的最大浓度为0.010μg/ ml,活性为0.061μg/ ml代谢物,5-羟基氟昔汀。几何平均值弗卢克丁的半衰期为20.71小时,22.62小时对于5-羟基氟灵线。计算为近似A透皮弗卢克丁后牛奶中的戒断时间管理是使用统计完成的公差限制程序。该分析表明遵守撤销时期将是谨慎的最后一次治疗后96小时。这不仅仅是两倍只有36小时的标记撤离期在使用可注射的制剂之后。撤回应申请这项工作的时期建议小心翼翼地,因为本研究没有进行美国要求的全部质量控制实践FDA用于全药批准研究。小心应该是在将这种戒断时间应用于患病时采取动物,用不同的挤奶挤奶的动物频率,以及不同生产阶段的频率由于这些都被证明会影响药物耗尽来自牛奶。

著录项

  • 来源
    《Journal of dairy science》 |2019年第12期|11465-11469|共5页
  • 作者单位

    Department of Veterinary Diagnostic and Production Animal Medicine Iowa State University Ames 50011;

    Department of Anatomy and Physiology Kansas State University Manhattan 66506;

    Department of Veterinary Diagnostic and Production Animal Medicine Iowa State University Ames 50011;

    Department of Anatomy and Physiology Kansas State University Manhattan 66506;

    Department of Anatomy and Physiology Kansas State University Manhattan 66506;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    dairy cattle; nonsteroidal antiinflammatory drug; milk residue;

    机译:乳牛;非甾体抗炎药;牛奶残留物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号